CD4 and glioblastoma: All CART products generated from patients with GBM (n = 4) contained a higher proportion of CD8+ T cells (Supplementary Fig. S5A and S5B), with a comparable CD8+: CD4+ ratio in CAR-expressing T cells (P > 0.05, one-way ANOVA with the Tukey test; Fig. 4C).